GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivo Bio Tech Ltd (BOM:511509) » Definitions » Cyclically Adjusted PB Ratio

Vivo Bio Tech (BOM:511509) Cyclically Adjusted PB Ratio : 1.45 (As of Jun. 10, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vivo Bio Tech Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Vivo Bio Tech's current share price is ₹40.22. Vivo Bio Tech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₹27.68. Vivo Bio Tech's Cyclically Adjusted PB Ratio for today is 1.45.

The historical rank and industry rank for Vivo Bio Tech's Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:511509' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.3   Med: 1.45   Max: 1.71
Current: 1.45

During the past years, Vivo Bio Tech's highest Cyclically Adjusted PB Ratio was 1.71. The lowest was 1.30. And the median was 1.45.

BOM:511509's Cyclically Adjusted PB Ratio is ranked better than
54.31% of 661 companies
in the Biotechnology industry
Industry Median: 1.67 vs BOM:511509: 1.45

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vivo Bio Tech's adjusted book value per share data for the three months ended in Mar. 2024 was ₹36.501. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹27.68 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vivo Bio Tech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Vivo Bio Tech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivo Bio Tech Cyclically Adjusted PB Ratio Chart

Vivo Bio Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.55

Vivo Bio Tech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.42 - 1.55

Competitive Comparison of Vivo Bio Tech's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Vivo Bio Tech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivo Bio Tech's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's Cyclically Adjusted PB Ratio falls into.



Vivo Bio Tech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Vivo Bio Tech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=40.22/27.68
=1.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivo Bio Tech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Vivo Bio Tech's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=36.501/153.0345*153.0345
=36.501

Current CPI (Mar. 2024) = 153.0345.

Vivo Bio Tech Quarterly Data

Book Value per Share CPI Adj_Book
201403 9.117 91.425 15.261
201406 0.000 94.103 0.000
201409 0.000 96.780 0.000
201412 0.000 96.780 0.000
201503 9.811 97.163 15.453
201506 0.000 99.841 0.000
201509 10.358 101.753 15.578
201512 0.000 102.901 0.000
201603 10.760 102.518 16.062
201606 0.000 105.961 0.000
201609 12.447 105.961 17.977
201612 0.000 105.196 0.000
201703 13.449 105.196 19.565
201706 0.000 107.109 0.000
201709 15.103 109.021 21.200
201712 0.000 109.404 0.000
201803 19.601 109.786 27.322
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 22.082 118.202 28.589
201906 0.000 120.880 0.000
201909 24.868 123.175 30.896
201912 0.000 126.235 0.000
202003 25.625 124.705 31.446
202006 0.000 127.000 0.000
202009 28.016 130.118 32.950
202012 0.000 130.889 0.000
202103 31.693 131.771 36.807
202106 0.000 134.084 0.000
202109 32.655 135.847 36.787
202112 0.000 138.161 0.000
202203 33.044 138.822 36.427
202206 0.000 142.347 0.000
202209 33.364 144.661 35.295
202212 0.000 145.763 0.000
202303 34.806 146.865 36.268
202306 0.000 150.280 0.000
202309 35.121 151.492 35.479
202312 0.000 152.924 0.000
202403 36.501 153.035 36.501

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vivo Bio Tech  (BOM:511509) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Vivo Bio Tech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Vivo Bio Tech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivo Bio Tech (BOM:511509) Business Description

Traded in Other Exchanges
N/A
Address
Number 8-2-672/ 5 and 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.

Vivo Bio Tech (BOM:511509) Headlines

No Headlines